about
Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndromeA role for homeostatic drive in the perpetuation of complex chronic illness: Gulf War Illness and chronic fatigue syndromeExercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjectsIdentification of marker genes for differential diagnosis of chronic fatigue syndromeHigh levels of type 2 cytokine-producing cells in chronic fatigue syndromeGastric emptying is slow in chronic fatigue syndromeA review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndromeOverlap between atypical depression, seasonal affective disorder and chronic fatigue syndromeEffect of fermented porcine placenta on physical fatigue in miceOvertrained horses alter their resting pulsatile growth hormone secretion.Cortisol suppression and hearing thresholds in tinnitus after low-dose dexamethasone challenge.Neuroaetiology of chronic fatigue syndrome: an overview.Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal studyThe effect of acclydine in chronic fatigue syndrome: a randomized controlled trial.Model-based therapeutic correction of hypothalamic-pituitary-adrenal axis dysfunction.The role of stress in absenteeism: cortisol responsiveness among patients on long-term sick leave.The increase of alpha-melanocyte-stimulating hormone in the plasma of chronic fatigue syndrome patientsVentromedial prefrontal cortex modulates fatigue after penetrating traumatic brain injury.Fatigue in multiple sclerosis: mechanisms, evaluation, and treatmentDNA methylation modifications associated with chronic fatigue syndrome.Neuroendocrine and immune contributors to fatigueAn Etiological Model for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome.High cocoa polyphenol rich chocolate may reduce the burden of the symptoms in chronic fatigue syndrome.Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue.Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome.Functional genomics of serotonin receptor 2A (HTR2A): interaction of polymorphism, methylation, expression and disease association.The chronic fatigue syndrome--an update.The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome.Combined dexamethasone/corticotropin-releasing factor test in chronic fatigue syndrome.Possible use of repeated cold stress for reducing fatigue in chronic fatigue syndrome: a hypothesis.Rehabilitation of decreased motor performance in patients with chronic fatigue syndrome: should we treat low effort capacity or reduced effort tolerance?A comparison of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome.Sleep-wake behavior in chronic fatigue syndrome.Process and outcome evaluation of vocational rehabilitation interventions in patients with prolonged fatigue complaints.Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome?Natural killer cells in patients with severe chronic fatigue syndrome.Effects of Sleep Fragmentation and Chronic Latent Viral Infection on Behavior and Inflammation in Mice.Brain-immune interactions and disease susceptibility.The overtraining syndrome in athletes: a stress-related disorder.
P2860
Q21090022-1C1A5A49-02AB-424F-8045-C6923A03564DQ23923003-F3047823-8E83-43E0-B0D0-62BC40EF2AB7Q24522299-79EEDDB2-BBCF-40CA-B38F-D5776EA30964Q24648930-C6EA92F8-9800-480E-B897-54D6A09271E1Q24684394-C7D4B433-EF06-4FEC-B72F-A253701CE68EQ24799757-A6863BE5-F630-4D7F-87A9-15A8670B6BC4Q27002620-B567F173-97FA-44C9-8E6F-533515DB77BBQ28304950-ACD0E13D-DB45-4617-8AB1-23029BC4BC6FQ28391838-FF9E6034-6B0A-4249-A6F6-CBA605D1CEACQ30412377-6D371E1E-58D3-45ED-8451-C939DCFE3F15Q30468438-37DF9A92-83F3-4B5C-B097-79A5E446875EQ31127930-E316D652-729B-4131-B9C3-A1CDB00344E2Q33259666-88377A36-AC11-4129-B96F-B5EB2B0C0251Q33285759-C5171925-2043-4DD9-ABDE-606F8AC32722Q33402443-8C501CDE-C15E-4EBE-935B-C59821089253Q33560289-F3C73418-D698-4455-A667-45D48E282A28Q33669450-63D8AE02-3DC6-43D2-B369-73FFEB439F6BQ33720781-CB5FB0B8-9EF4-4202-80E2-3138C7D5D3D1Q34021881-8D9232C9-0322-4A70-BCD5-AAEAB74376A6Q34027879-07A11406-B9CD-46F6-A178-2C388467A83BQ34103068-827877B0-A334-4310-BA9E-6F2838D8CADBQ34213569-D07CD499-B7E0-45F0-AC07-8395E05D61C2Q34219361-812119BC-8A0E-4C6E-97A9-1FFB3FA8012FQ34404797-D8FA6995-241A-404B-AD7F-CB44D96F82C8Q34513067-9666F80C-A534-4172-8B34-7EEB7D2057FBQ34532832-AE4675CD-D159-4757-9528-11A6BF46A676Q34605428-41AA72F5-2A01-44B5-BECC-5A7D461F964CQ34617401-8AB72BE5-74D9-49FE-970D-C9EA638700A0Q34622270-F91E105C-4BC8-4D84-BBA7-1D4962F6A9ECQ34679445-915A89B2-532E-488A-8717-0BAA6E5A884DQ34706465-FAFB5E4F-50F1-4887-B1E3-EC0EEA0C90A3Q34718741-963E7479-79E9-4F33-9BBB-AF422C6766A7Q34783246-03D0C9E5-E023-48F8-B124-E935DCC57994Q34821577-ED0FD3E7-D5B4-4503-BF25-00FCAF998708Q34940405-8E566A56-2985-43B0-9522-FA1F6523EC2EQ34992592-0E672B25-619A-479B-AA26-1EDDD32636F1Q35309120-27B952AE-17D5-4AE5-AC75-2F54A46D68E4Q35798450-32D290AF-55EE-4793-9902-D24FCA48A0C6Q36026815-B1FD8C3D-4D90-476C-8B5A-3B47A952D838Q36045732-40F341A7-F028-40C1-8E57-1CD385904F0C
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The neuroendocrinology of chronic fatigue syndrome.
@ast
The neuroendocrinology of chronic fatigue syndrome.
@en
The neuroendocrinology of chronic fatigue syndrome.
@nl
type
label
The neuroendocrinology of chronic fatigue syndrome.
@ast
The neuroendocrinology of chronic fatigue syndrome.
@en
The neuroendocrinology of chronic fatigue syndrome.
@nl
prefLabel
The neuroendocrinology of chronic fatigue syndrome.
@ast
The neuroendocrinology of chronic fatigue syndrome.
@en
The neuroendocrinology of chronic fatigue syndrome.
@nl
P356
P1433
P1476
The neuroendocrinology of chronic fatigue syndrome.
@en
P2093
Anthony J Cleare
P304
P356
10.1210/ER.2002-0014
P577
2003-04-01T00:00:00Z